Principal Financial Analyst - Global Quality

Additional Location(s):  N/A

Diversity - Innovation - Caring - Global Collaboration - Winning Spirit - High Performance

At Boston Scientific, we’ll give you the opportunity to harness all that’s within you by working in teams of diverse and high-performing employees, tackling some of the most important health industry challenges. With access to the latest tools, information and training, we’ll help you in advancing your skills and career. Here, you’ll be supported in progressing – whatever your ambitions.       

About the Role:

The Principal Financial Analyst will serve as a key finance partner to the Global Quality organization, providing accounting leadership, complex financial analysis, and decision support to the organization. This role is mainly responsible for budgeting, tracking, analysis, and audit support of global quality and regulatory functions and related initiatives. 

Key Responsibilities Include:

• Serve as key business partner to quality and regulatory functions, drive adherence to corporate targets and provide actionable recommendations.
• Perform all aspects of the monthly financial close process including necessary journal entries, balance sheet reconciliations, global project consolidation/reconciliation, variance/trend analysis
• Prepare and present monthly financial reporting package and financial insight to GSC, quality, regulatory, and corporate finance leadership
• Lead spend and headcount budgeting activities for global quality and regulatory functions and initiatives.
• Support ad-hoc requests and projects when necessary.
• Support value improvement program for the function by providing finance expertise to estimate and validate savings assumptions. 
• Drive continuous improvement within our financial processes to gain efficiency.
• Utilize Hyperion, SAP, Tableau, and Excel to review, analyze, and reconcile data

Required Qualifications:

• Bachelor’s degree in accounting, finance, or related field.
• 5+ years Accounting/ Finance experience
• Advanced Excel skills and comfort working with large data sets.
• Exceptional organizational and time management skills are crucial.  Able to manage multiple priorities and deadlines.
• Strong analytical, problem-solving, and communication skills, with the ability to explain financial results to non-finance partners.
• Detail-oriented with a strong sense of ownership and accountability.
• Collaborative, proactive, and comfortable working with cross-functional teams.

Preferred Qualifications:

• Experience working with Hyperion
• 7+ years of progressive experience in FP&A or a similar finance role
• MBA or CPA (or progress toward certification)
• Project accounting experience strongly preferred
• Ability to influence business partners and drive process improvements.
• Experience in a large, global, or matrixed organization. Background in medical device or life sciences industry is a plus.

Requisition ID: 632477

Minimum Salary: $106800 

Maximum Salary: $202900 

The anticipated compensation listed above and the value of core and optional employee benefits offered by Boston Scientific (BSC) – see www.bscbenefitsconnect.com—will vary based on actual location of the position and other pertinent factors considered in determining actual compensation for the role. Compensation will be commensurate with demonstrable level of experience and training, pertinent education including licensure and certifications, among other relevant business or organizational needs. At BSC, it is not typical for an individual to be hired near the bottom or top of the anticipated salary range listed above.

Compensation for non-exempt (hourly), non-sales roles may also include variable compensation from time to time (e.g., any overtime and shift differential) and annual bonus target (subject to plan eligibility and other requirements).

Compensation for exempt, non-sales roles may also include variable compensation, i.e., annual bonus target and long-term incentives (subject to plan eligibility and other requirements).

For MA positions: It is unlawful to require or administer a lie detector test for employment. Violators are subject to criminal penalties and civil liability.

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and follow us on LinkedIn.

Boston Scientific Corporation has been and will continue to be an equal opportunity employer. To ensure full implementation of its equal employment policy, the Company will continue to take steps to assure that recruitment, hiring, assignment, promotion, compensation, and all other personnel decisions are made and administered without regard to race, religion, color, national origin, citizenship, sex, sexual orientation, gender identity, gender expression, veteran status, age, mental or physical disability, genetic information or any other protected class.

Please be advised that certain US based positions, including without limitation field sales and service positions that call on hospitals and/or health care centers, require acceptable proof of COVID-19 vaccination status.  Candidates will be notified during the interview and selection process if the role(s) for which they have applied require proof of vaccination as a condition of employment.  Boston Scientific continues to evaluate its policies and protocols regarding the COVID-19 vaccine and will comply with all applicable state and federal law and healthcare credentialing requirements.   As employees of the Company, you will be expected to meet the ongoing requirements for your roles, including any new requirements, should the Company’s policies or protocols change with regard to COVID-19 vaccination.